Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 39 of 39 entries
View as:

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Phase: N/A Priority: Normal
NCT ID: NCT04181723 Org: User:
Start: 11/06/19 End: 10/28/21 Due: 10/28/22

Open-Label Extension Study of Trofinetide for Rett Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04776746 Org: User:
Start: 11/08/20 End: 06/30/23 Due: 06/30/24

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06173531 Org: User:
Start: 11/27/23 End: 06/30/26 Due: 06/30/27

An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04988867 Org: User:
Start: 09/22/21 End: 05/31/23 Due: 05/31/24

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Phase: N/A Priority: Normal
NCT ID: NCT03482882 Org: User:
Start: 03/09/18 End: 07/24/19 Due: 07/24/20

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03121586 Org: User:
Start: 01/31/17 End: 06/30/24 Due: 06/30/25

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Phase: N/A Priority: Normal
NCT ID: NCT03623321 Org: User:
Start: 07/17/18 End: 05/05/23 Due: 05/05/24

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Phase: N/A Priority: Normal
NCT ID: NCT04855240 Org: User:
Start: 03/29/21 End: 03/14/22 Due: 03/14/23

A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT02035553 Org: User:
Start: 11/30/13 End: 10/27/16 Due: 10/27/17

Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05555615 Org: User:
Start: 11/02/22 End: 02/14/25 Due: 02/14/26

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT04292223 Org: User:
Start: 02/10/20 End: 04/26/22 Due: 04/26/23

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Phase: N/A Priority: Normal
NCT ID: NCT00361166 Org: User:
Start: 08/31/05 End: 03/31/07 Due: 03/31/08

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT05008835 Org: User:
Start: 07/20/21 End: 11/16/22 Due: 11/16/23

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Phase: N/A Priority: Normal
NCT ID: NCT02992132 Org: User:
Start: 11/30/16 End: 02/16/18 Due: 02/16/19